A recent study from our lab corroborated these findings via the immunohistochemistry of premalignant and malignant tissues, which showed MUC4 was significantly reduced in the adenoma-carcinoma sequence relative to normal tissue [11]. This evidence concerns the gene MUC4 and adenoma.